{"id":110800,"date":"2021-03-29T19:24:36","date_gmt":"2021-03-29T19:24:36","guid":{"rendered":"https:\/\/fin2me.com\/?p=110800"},"modified":"2021-03-29T19:24:36","modified_gmt":"2021-03-29T19:24:36","slug":"earnings-previews-blackberry-lululemon-chewy-walgreens","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/earnings-previews-blackberry-lululemon-chewy-walgreens\/","title":{"rendered":"Earnings Previews: BlackBerry, Lululemon, Chewy, Walgreens"},"content":{"rendered":"
Monday afternoon\u2019s and Tuesday morning\u2019s noteworthy earnings reports included just two stocks, an EV maker and the co-developer of a COVID-19 vaccine.<\/p>\n
Tuesday afternoon\u2019s and Wednesday morning\u2019s noteworthy earnings reports include a security software company, a sports apparel giant, a pet supply company and a Dow 30 component.\n\t\t\t<\/p>\n
BlackBerry Ltd. (NYSE: BB) was once the world\u2019s largest maker of cell phones. The company was late to the switch to smartphones, though, and it has repurposed itself as a supplier of security software and a platform for automobile automation. Last year shares posted an overall gain of about a third before dropping back to a bump of just 3.3% for the full year.<\/p>\n
The stock spiked again in late January when retail investors went after short sellers in the stock and drove the price up by more than 275%. Shares were up about a third for the year to date at Friday\u2019s close.<\/p>\n
The most recent analyst ratings on the stock were downgrades, essentially from Neutral to Sell. With the shares trading at around $9.30 on Monday and a consensus price target of $7.69, the stock likely is overpriced.<\/p>\n
Analysts expect BlackBerry to post fiscal fourth-quarter 2021 quarterly earnings per share (EPS) of $0.03 on revenue of $245.1 million when it reports results Tuesday after markets close. That\u2019s a year-over-year drop of two-thirds in EPS and a 16% decline in revenue. For the full 2021 fiscal year, the company is forecast to post EPS of $0.18 (up 38%) on sales of $942.2 million (down 14.3%).<\/p>\n
At Monday\u2019s price, the shares trade at a multiple of 53 times expected 2021 earnings, 63 times expected 2022 earnings and 64 times expected 2023 earnings.<\/p>\n
Last year, Lululemon Athletica Inc. (NASDAQ: LULU) posted a bump of more than 50% in its share price, even including a drop of more than 40% in mid-March. When the company reports fourth-quarter 2020 results after markets close Tuesday, analysts are expecting the athletic apparel maker to post solid gains over the prior quarter and full year.<\/p>\n
Analysts remain bullish on the stock, with Piper Sandler Monday morning maintaining its Overweight rating while lowering the price target from $490 to $478. Last week Morgan Stanley maintained its Equal Weight rating and lowered the price target from $400 to $386. The stock is down about 10% so far in 2021, due in part to investors deciding that pandemic winners like Lululemon are not going to continue posting big numbers. Piper Sandler sees the lower price as a \u201ccompelling entry point.\u201d<\/p>\n
Fourth-quarter EPS is forecast at $2.49, up 9.2% year over year, and revenue is forecast up 18.9% at $1.66 billion. For the full fiscal year, Lululemon is expected to report EPS of $4.58, down about 7% year over year, on sales of $4.33 billion, up 8.9%.<\/p>\n
Lululemon\u2019s stock traded at around $311 Monday morning, in a 52-week range of $177.77 to $399.90. The consensus price target on the stock is $403, implying an upside potential of nearly 30%.\n\t\t<\/p>\n